Erratum zu: Molekulare Klassifikation des Endometriumkarzinoms – ein kurzer Überblick
- PMID: 38334804
- DOI: 10.1007/s00292-024-01297-7
Erratum zu: Molekulare Klassifikation des Endometriumkarzinoms – ein kurzer Überblick
Erratum for
-
[Molecular classification of endometrial carcinoma-a short summary for clinical use].Pathologie (Heidelb). 2023 Nov;44(6):392-400. doi: 10.1007/s00292-023-01238-w. Pathologie (Heidelb). 2023. PMID: 37815668 Review. German.
References
Literatur
-
- TCGA—Cancer Genome Atlas Research Network, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, Yau C, Laird PW, Ding L, Zhang W, Mills GB, Kucherlapati R, Mardis ER, Levine DA (2013) Integrated genomic characterization of endometrial carcinoma. Nature 497(7447):67–73 - DOI
-
- León-Castillo A, de Boer SM, Powell ME, Mileshkin LR, Mackay HJ, Leary A, Nijman HW, Singh N, Pollock PM, Bessette P, Fyles A, Haie-Meder C, Smit VTHBM, Edmondson RJ, Putter H, Kitchener HC, Crosbie EJ, de Bruyn M, Nout RA, Horeweg N, Creutzberg CL, Bosse T, TransPORTEC consortium (2020) Molecular classification of the PORTEC‑3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy. J Clin Oncol 38(29):3388–3397 - DOI - PubMed - PMC